Story perspectives

Trump Announces Gene Therapy Approval, Navy Shake-up, Drug-Pricing Deal

4/25/2026

Center

Trump Announces Approvals

President Donald Trump announced FDA approval of Regeneron’s gene therapy Otarmeni, which restored hearing in nine of twelve trial children.
John Phelan was dismissed as U.S. Navy Secretary on April 23, 2026, with Vice Admiral Hung Cao named as his successor.
The removal followed disputes over naval shipbuilding and outsourcing linked to the AUKUS submarine program.
Trump announced a drug-pricing agreement to bring U.S. prices in line with other developed nations.

Left

Trump Approval Plunge

Independent voters gave President Donald Trump a 23% approval rating, the lowest level recorded in his second term.
President Donald Trump’s overall approval sits at 33% and his economic rating is –32 points, the worst in fifty years.
Only 21% of independent voters back the war on Iran, showing broad opposition.
Analysts warn the low ratings could cost Republicans House control and risk Senate majority.

1 of 2

Trump Announces Approvals

President Donald Trump announced FDA approval of Regeneron’s gene therapy Otarmeni, which restored hearing in nine of twelve trial children.
John Phelan was dismissed as U.S. Navy Secretary on April 23, 2026, with Vice Admiral Hung Cao named as his successor.
The removal followed disputes over naval shipbuilding and outsourcing linked to the AUKUS submarine program.
Trump announced a drug-pricing agreement to bring U.S. prices in line with other developed nations.

1 / 2